[ Price : $8.95]
FDA warns Parker, CO-based Oralabs about CGMP violations in its work as a contract drug manufacturer.[ Price : $8.95]
FDA warns Indias Flowchem Pharma about significant CGMP deviations in its production of active pharmaceutical ingredients.[ Price : $8.95]
BioMarin says it is discontinuing dosing and enrollment in portions of its mid-stage clinical program for Voxzogo (vosoritide) aft...[ Price : $8.95]
Integra LifeSciences recalls certain neurosurgical monitoring kits, citing potential safety risks linked to a needle component use...[ Price : $8.95]
FDA sends Japanese active pharmaceutical ingredient maker Alps Pharmaceutical a Form 483 from an inspection that identified multip...[ Price : $8.95]
Four stakeholders praise an FDA draft guidance on using Bayesian methods in clinical trial design and suggest ways to improve the ...[ Price : $8.95]
Two Akin attorneys review a 3/9 FDA draft guidance recommending ways in which it would like to see human and drug manufacturers re...[ Price : $8.95]
FDA sends Aldeyra a complete response letter for its investigational dry eye treatment reproxalap, concluding that the company fai...